Sofia Sees Hope Lauds FDA Approval of LUXTURNA™
LUXTURNA™ (voretigene neparvovec), is the first pharmacologic treatment for inherited retinal disease and the first gene therapy for a genetic disease in the US Ledyard, CT (Dec. 19, 2017) — […]
Archives
Tag Archives for: "Luxturna"